Movement Alert|Salesforce.com Rises 3.34% in Regular Trading, Agentforce Product Expansion and Dreamforce Conference Anticipation Fuel Gains

Market Focus
Sep 14

On September 14, Salesforce.com rose 3.34% in regular trading, trading at $252.70/share, with turnover of $579 million.

On the news front, the company recently launched a new series of ready-to-use Agentforce AI agents spanning sales, service, commerce, and back-office operations, further expanding its AI product matrix. Meanwhile, RBC Capital Markets noted that Salesforce.com is expected to unveil details on Claudeforce — its collaboration with Anthropic — at the upcoming Dreamforce conference, including product capabilities, pricing structure, and early customer traction, driving heightened market expectations.

The Dreamforce catalyst follows strong momentum from Salesforce.com's Q2 earnings beat in late August, which saw the stock surge over 20% after revenue of $11.35 billion and EPS of $5.90 exceeded estimates. The company also raised its full-year fiscal 2027 guidance, with revised revenue expectations of $46.1 billion to $46.4 billion. Analysts at TD Cowen and Oppenheimer have highlighted the strategic significance of the Anthropic partnership in countering the SaaS displacement narrative, with multiple firms raising their price targets.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10